by Nisha Cooch, PhD | Feb 26, 2020 | Neurology News, News, Nursing News, Pediatricians News, Pulmonologist News, Radiology News, Urologists News
Perhaps the biggest SMA news this month has been the success of Roche’s Sunfish trial, but fundamental research, such as those into the mechanisms of the disease and the implications of certain interventions, continue. Below is a roundup of the latest news and...
by Nisha Cooch, PhD | Feb 18, 2020 | Neurology News, News, Nursing News, Orthopedics News, Pediatricians News, Physical Therapists News, Pulmonologist News, Radiology News, slider, Urologists News
Research on SMA continues to forge ahead in 2020, with new results in from Roche’s latest investigation into its oral SMA drug, risdiplam. New tools for screening are being revealed as legislative changes are pushing more and more toward requiring infants born in the...
by Nisha Cooch, PhD | Jan 27, 2020 | Neurology News, News, Nursing News, Pulmonologist News, Radiology News, slider
New SMA research and news related to newborn screening and the upcoming FDA evaluation of a new drug have kicked off 2020. Below is a roundup of the latest on SMA. Understanding SMA Serum creatinine is a biomarker of progressive denervation in spinal muscular...
by Nisha Cooch, PhD | Dec 13, 2019 | Neurology News, News, Orthopedics News, Pediatricians News
Several new papers on the mechanisms underlying SMA have been published in recent weeks, and data on pertinent SMA treatments continue to be collected and shared. Importantly, researchers also continue to consider how the science and medicine around SMA can best be...
by Nisha Cooch, PhD | Dec 9, 2019 | Genetic Counselors News, Neurology News, News, Orthopedics News, Pediatricians News, Physical Therapists News, Pulmonologist News
Regulators continue to review SMA drugs and consider policies related to newborn screening while new data emerge related to the mechanisms underlying the disease, as well as those concerning management and treatment. Here is a roundup of some of the latest news and...
